← Leaderboards
Warren J Manning
Beth Israel Deaconess Medical Center
$7,083,412
Attributed
$7,083,412
Total exposure
6
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $863.4K · FY2005–12$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$7,083,412 · 6
By mechanism
R01$6,503,040 · 2
M01$387,832 · 3
S10$192,540 · 1
Top collaborators
No co-investigators on record.
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Robert E Gerszten$34,860,502
- Young-Bum Kim$17,058,086
- Francine K Welty$7,046,001
- Mark Andrew Sarzynski$4,936,886
- Olivier N. Kocher$4,214,595
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectClinical ResearchMagnetic Resonance ImagingDiagnosis Design /EvaluationObesityAtherosclerosisBioimaging /Biomedical ImagingDisease /Disorder Proneness /RiskHeart Imaging /Visualization /ScanningHormone Regulation /Control MechanismAcute Phase ProteinHeart Disorder DiagnosisAngiocardiographyHeart FunctionCoronary DisorderCardiovascular Disorder DiagnosisCardiovascular Imaging /VisualizationDiagnosis Quality /StandardAdipocytesBiochemicalAmericanAge DifferenceAcute-Phase ProteinsBlood Circulation
Grant awards (22)
Imaging of Aortic Atherosclerosis and Inflammation in the Metabolic Syndrome$799,242
R01 · FY2012 · HL · contact PI
Imaging of Aortic Atherosclerosis and Inflammation in the Metabolic Syndrome$823,001
R01 · FY2010 · HL · contact PI
Imaging of Aortic Atherosclerosis and Inflammation in the Metabolic Syndrome$823,860
R01 · FY2009 · HL · contact PI
Imaging of Aortic Atherosclerosis and Inflammation in the Metabolic Syndrome$863,379
R01 · FY2008 · HL · contact PI
Cardiac MR of Subclin CVD: Impact of Age$397,079
R01 · FY2005 · HL
Cardiac MR of Subclin CVD: Impact of Age$397,080
R01 · FY2004 · HL
Cardiac MR of Subclin CVD: Impact of Age$817,061
R01 · FY2003 · HL
Cardiac MR of Subclin CVD: Impact of Age$770,355
R01 · FY2002 · HL
HORMONAL DETERMINANTS OF CARDIAC FUNCTION IN OBESITY$0
M01 · FY2002 · RR
SAFETY AND EFFACY OF CORONARY MAGNETIC RESONANCE ANGIOGRAPHY WITH MS 325$0
M01 · FY2002 · RR
Cardiac MR of Subclin CVD: Impact of Age$811,983
R01 · FY2001 · HL
HORMONAL DETERMINANTS OF CARDIAC FUNCTION IN OBESITY$0
M01 · FY2001 · RR
SAFETY AND EFFACY OF CORONARY MAGNETIC RESONANCE ANGIOGRAPHY WITH MS 325$0
M01 · FY2001 · RR
IMPACT OF OLESTRA ON ANTICOAGULATION IN PATIENTS W/ WARFARIN$193,916
M01 · FY2000 · RR
IMPACT OF OLESTRA ON ANTICOAGULATION IN PATIENTS W/ WARFARIN$193,916
M01 · FY2000 · RR
SMALL ANIMAL ECHOCARDIOGRAPHIC IMAGING SYSTEMS$192,540
S10 · FY2000 · RR
SAFETY AND EFFACY OF CORONARY MAGNETIC RESONANCE ANGIOGRAPHY WITH MS 325$0
M01 · FY2000 · RR
SAFETY AND EFFACY OF CORONARY MAGNETIC RESONANCE ANGIOGRAPHY WITH MS 325$0
M01 · FY2000 · RR
HORMONAL DETERMINANTS OF CARDIAC FUNCTION IN OBESITY$0
M01 · FY2000 · RR
HORMONAL DETERMINANTS OF CARDIAC FUNCTION IN OBESITY$0
M01 · FY2000 · RR
HORMONAL DETERMINANTS OF CARDIAC FUNCTION IN OBESITY$0
M01 · FY2000 · RR
SAFETY AND EFFACY OF CORONARY MAGNETIC RESONANCE ANGIOGRAPHY WITH MS 325$0
M01 · FY2000 · RR